Boditech Med (206640.KQ) Stock Price

Boditech Med Price

KOSDAQ·CLOSED
8,510.00
​
Market closed

Over the last 10 years Boditech Med grew revenue by 15.1% annually, reaching 162.09 B KRW. Earnings per share have grown at 7.9% per year over the last 9 years. For Boditech Med, the net margin of 14.6% is down versus 28.1% a few years ago. At today's price the dividend yield works out to roughly 1.76%. The payout ratio is around 14% of earnings. The dividend has grown at 5.7% per year over the past 9 years.

Boditech Med stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Boditech Med business model & stock analysis

Boditech Med, Inc. generates revenue through the manufacture and sale of in-vitro diagnostics analyzers and reagents, including antigen diagnostic kits, cancer diagnostic kits, and drug concentration diagnostic kits. The company serves domestic and overseas markets with its products, focusing on diagnostic solutions for healthcare providers and laboratories. Its product portfolio targets medical professionals seeking reliable testing tools for disease detection and treatment monitoring. The firm's primary customers are healthcare institutions and diagnostic laboratories that require specialized testing equipment and consumables. By offering a range of diagnostic kits for various medical applications, Boditech Med addresses the needs of both local and international clients in the healthcare sector. The company's products are designed to support clinical decision-making through accurate and efficient diagnostic processes.

Frequently asked questions about Boditech Med

5 analysts currently rate the Boditech Med stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Boditech Med to generate revenue of 196.00 B KRW and earnings per share of 2,035.57 KRW.

Converted at the current exchange rate, the Boditech Med share trades at 5.65 EUR (8,510.00 KRW).

The Boditech Med share (206640.KQ) is listed on 1 stock exchanges, including: KOSDAQ (Seoul) (206640.KQ).

The expected revenue of Boditech Med is 196.00 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Boditech Med is 44.19 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Boditech Med is currently 4.18. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Boditech Med stock.

The price-to-sales ratio (P/S) of Boditech Med is currently 0.94. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Boditech Med stock.

The Eulerpool Quality Score for Boditech Med is 6/10.

The ISIN of Boditech Med is KR7206640005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Boditech Med is 206640.KQ. The ticker symbol is used to trade Boditech Med shares on the stock exchange.

Fair ValueTerminal
7,999.40 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Dec 29, 2014
ISIN
KR7206640005
Cusip
Y04333103
Market capitalization
186.71 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
4.23
P/S
P/Se
0.94
EV/EBIT
6.17
P/B Ratio
0.81
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.75 %
Dividend
Dividend yield
1.76 %
Est. Dividend Yield
1.76 %
Payout Ratio
13.77 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
2 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Nov 3, 2026, 3:43 AM

Boditech Med Peer Group

Boditech Med Ticker

KOSDAQ · 206640.KQ

Boditech Med FIGI

206640:KS · BBG007KK2ZS7206640:KQ · BBG007KK2ZV3

All fundamentals and in-depth analysis of Boditech Med

Our stock analysis for Boditech Med stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Boditech Med. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.